Previous Article | Next Article ![]()
Infection and Immunity, April 2001, p. 2732-2735, Vol. 69, No. 4
Centre for Veterinary Science, Department of
Clinical Veterinary Medicine, University of Cambridge, Cambridge
CB3 0ES,1 and Institute for Animal
Health, Compton, Newbury, Berkshire RG20 7NN,2
United Kingdom
Received 24 July 2000/Returned for modification 29 August
2000/Accepted 2 January 2001
A defined allelic-replacement mutant of the sly gene,
encoding a thiol-activated cytolysin, from a European isolate of
Streptococcus suis serotype 2 was generated and
characterized. Unlike the parental strain, it is nonhemolytic,
noncytotoxic for cultured macrophage-like cells, avirulent in a mouse
infection model, yet only slightly attenuated in a porcine model of
systemic infection.
Streptococcus suis has
been described as the etiological agent for a number of infectious
disease syndromes in pigs, including arthritis, septicemia, meningitis,
and pneumonia. S. suis produces a secreted hemolysin
(suilysin) which has been suggested as playing a role in virulence
(2, 4-7, 10). In order to investigate the role played by
suilysin in the pathogenesis of a European serotype 2 isolate of
S. suis, we generated a defined allelic-replacement mutant
of the sly gene and compared the wild-type organism with the
sly mutant in a number of assays.
Bacterial strains and media.
S. suis type 2 strain
P1/7 was grown on Columbia agar (Oxoid) containing 10% defibrinated
horse blood or in liquid cultures of Todd-Hewitt broth (Oxoid)
supplemented with 7% fetal calf serum (FCS) (Gibco).
Allelic-replacement mutants of S. suis were maintained on 1 µg of erythromycin (Sigma) per ml.
Mutagenesis of the suilysin gene from S. suis type
2.
An erythromycin resistance gene cassette was introduced into an
EcoRV site within a 1,278-bp fragment of the sly
gene, contained in the vector pT7-Blue (Stratagene), amplified by PCR
using primers suis1 (5'-AGCTTGACTTACGAGCCACAAGAG-3') and
suis2 (5'-CCACCATTCCCAAGCTAATCCTGT-3') with chromosomal DNA
from P1/7 as a template. The resulting plasmid, pSUI-erm, contains the
erm gene in the same orientation as the sly gene.
Plasmid pSUI-erm was introduced into P1/7 by electroporation (22.5 V/cm, 25 µF, and 1,000 Phenotypic analysis of S7c.
Overnight growth of suilysin
mutant S7c on Columbia blood agar plates revealed no
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.4.2732-2735.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Generation and Characterization of a Defined Mutant
of Streptococcus suis Lacking Suilysin

![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
). A transformant which had undergone a
double-crossover event, confirmed by Southern hybridization and PCR,
with concomitant insertion mutation of the sly gene, was
isolated and named S7c.
-hemolysis.
Secreted proteins from anaerobically grown overnight cultures of P1/7
and S7c were concentrated 100-fold by ammonium sulfate (50%, wt/vol)
precipitation; then 10 µl each of these preparations was spotted onto
a Columbia horse blood agar plate and incubated at 37°C for 30 min.
The proteins from P1/7 show clear zones of hemolysis, whereas there is
a complete absence of hemolytic activity in the proteins obtained from
S7c (Fig. 1a). The hemolytic activity
from the wild-type parental bacteria was enhanced by the addition of
-mercaptoethanol, as previously reported (7) (Fig. 1a).

View larger version (43K):
[in a new window]
FIG. 1.
Characterization of P1/7 and S7c culture supernatants.
(a) Overnight culture supernatants from wild type P1/7 (wt) and S7c
(S7c) were concentrated 100-fold by ammonium sulfate precipitation, and
10-µl samples, indicated by circles, were overlaid onto a 7%
(vol/vol) horse blood agar plate, followed by incubation at 37°C for
60 min. Samples in track B were treated with
-mercaptoethanol to a
final concentration of 1 mM. PBS, phosphate-buffered saline. (b)
Western blot of culture supernatants from P1/7 and S7c using
antisuilysin monoclonal antibody. Proteins secreted from overnight
culture supernatants from P1/7 (track A) and S7c (track B) were
concentrated 25 times, separated on a polyacrylamide gel, and Western
blotted onto nitrocellulose, followed by development with a monoclonal
antibody specific for suilysin. The band corresponding to suilysin in
track A is completely absent from track B. Molecular weights are in
thousands.
Cell culture and cytotoxicity assay.
Murine macrophage-like
J774.2 cells were split into 96-well plates (approximately 1.5 × 105 cells/well) and maintained in Dulbecco modified Eagle
medium supplemented with 3% FCS and 2 mM glutamine (assay buffer).
Bacterial inocula (5 × 107 CFU per 100 µl, in assay
buffer), generated from overnight cultures of P1/7 and S7c, were added
to three experimental wells and incubated at 37°C with 5% carbon
dioxide for 3 and 5 h. Relative cytotoxicity was assayed as
lactate dehydrogenase (LDH) release as determined by the CytoTox96 kit
(Promega). The experiment was repeated on three separate occasions
(Fig. 2). The parental strain, P1/7, caused extensive damage to cell monolayers in a time-dependent manner.
In comparison, S7c elicited only approximately 4% of maximal LDH
release after 5 h of incubation. Bacterial viable counts during the experiment revealed identical numbers of CFU for P1/7 and S7c.
These experiments show that S. suis efficiently kills J774.2 cells and that this effect is dependent on the presence of suilysin, which is thus probably the only cytolysin produced by S. suis.
|
Mouse infection experiments. Overnight cultures of P1/7 and S7c, grown in Todd-Hewitt broth containing 10% FCS, were diluted in the same medium to achieve 108, 107, 106, and 105 CFU/0.5-ml dose. These 0.5-ml inocula were introduced intraperitoneally into 5-week-old female BALB/c mice, in groups of five mice per inoculum. Mice were monitored over a period of 1 week, during which deaths were recorded and moribund animals were humanely killed. Inoculation of 108 and 107 wild-type bacteria killed 9 of 10 mice and 8 of 10 mice, respectively, over the two experiments, within 48 h, providing 50% lethal doses (9) of log 6.45 and log 6.73, respectively, whereas all mice infected with S7c survived. These data show unequivocally that mutation of suilysin prevents S. suis from killing mice via the intraperitoneal route of infection.
Pig infection experiment. Pigs, aged between 35 and 40 days, were obtained from Cotswold Pigs Ltd. (Colsterworth Farm, United Kingdom). Fourteen days prior to challenge, animals were screened for the presence of major pathogens and injected with ceftiofur (Excenel; Pharmacia & Upjohn Ltd.) for three consecutive days. Bacteria for challenge were grown overnight in brain heart infusion broth at 37°C and were subcultured in the same medium for 6 h at 37°C. Cultures were diluted in phosphate-buffered saline (pH 7.2), and each animal was challenged by intravenous injection of 1 ml of phosphate-buffered saline containing between 1 × 106 and 5 × 106 CFU of either strain S7c (group 1) or P1/7 (group 2). Animals were monitored for clinical signs of disease every 3 h; piglets showing marked signs of illness were killed for postmortem examination. Surviving animals were killed for postmortem examination 44 h postinfection. At postmortem, a visual inspection was made in order to detect pathological lesions and swabs were taken from heart blood, the lateral ventricle of the brain, the lungs, the serous cavity, and two limbs for bacterial examination. Results (lesion scores, bacteriology, survival times) between groups were analyzed statistically using Student's t test via MINITAB release 12.1 for Windows. Tests were performed assuming equal variance and were repeated assuming unequal variance where necessary.
The results of the challenge experiment are summarized in Table 1. Two pigs infected with S7c and one infected with P1/7 showed signs of clinical disease by 12 h postinfection, with marked lameness, shivering, and vomiting. By 15 h postinfection, three pigs challenged with S7c and all five infected with P1/7 were affected, typical signs being dullness, swollen joints, and dyspnea. Three pigs infected with P1/7 and three infected with S7c required euthanasia commencing 21 h postinfection, due to severe lameness. A fourth pig infected with P1/7 showed signs of meningitis (wide-based stance, rigid posture, ataxia, and muscle tremors). At 44 h postinfection the experiment was terminated, by which time only one pig infected with P1/7 and two pigs infected with S7c were left alive. Mean survival times were not significantly different between groups.
|
| |
ACKNOWLEDGMENTS |
|---|
The Wellcome Trust RCDF (051033) awarded to A. G. Allen supported the work performed at the University of Cambridge, and the Institute for Animal Health, Compton, is supported by the BBSRC.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Centre for Veterinary Science, Department of Clinical Veterinary Medicine, University of Cambridge, Madingley Rd., Cambridge, CB3 0ES, United Kingdom. Phone: 44 1223 339868. Fax: 44 1223 337610. E-mail: djm47{at}cam.ac.uk.
Present address: Arrow Therapeutics Ltd., Carshalton, Surrey,
SM5 4DS, United Kingdom.
Editor: E. I. Tuomanen
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Charland, N.,
V. Nizet,
C. E. Rubens,
K. S. Kim,
S. Lacouture, and M. Gottschalk.
2000.
Streptococcus suis serotype 2 interactions with human brain microvascular endothelial cells.
Infect. Immun.
68:637-643 |
| 2. |
Feder, I.,
M. M. Chengappa,
B. Fenwick,
M. Rider, and J. Staats.
1994.
Partial characterization of Streptococcus suis type 2 hemolysin.
J. Clin. Microbiol.
32:1256-1260 |
| 3. | Friedland, I. R., M. M. Paris, S. Hickey, S. Shelton, K. Olsen, J. C. Paton, and G. H. McCracken. 1995. The limited role of pneumolysin in the pathogenesis of pneumococcal meningitis. J. Infect. Dis. 172:805-809[Medline]. |
| 4. |
Gottschalk, M. G.,
S. Lacouture, and J. D. Dubreuil.
1995.
Characterization of Streptococcus suis capsular type 2 haemolysin.
Microbiology
141:189-195 |
| 5. | Jacobs, A. A., A. J. van den Berg, J. C. Baars, B. Nielsen, and L. W. Johannsen. 1995. Production of suilysin, the thiol-activated haemolysin of Streptococcus suis, by field isolates from diseased pigs. Vet. Rec. 137:295-296[Medline]. |
| 6. |
Jacobs, A. A.,
A. J. van den Berg, and P. L. Loeffen.
1996.
Protection of experimentally infected pigs by suilysin, the thiol-activated haemolysin of Streptococcus suis.
Vet. Rec.
139:225-228 |
| 7. |
Jacobs, A. A. C.,
P. L. W. Loeffen,
A. J. G. van den Berg, and P. K. Storm.
1994.
Identification, purification, and characterization of a thiol-activated hemolysin (suilysin) of Streptococcus suis.
Infect. Immun.
62:1742-1748 |
| 8. | Norton, P. M., C. Rolph, P. N. Ward, R. W. Bentley, and J. A. Leigh. 1999. Epithelial invasion and cell lysis by virulent strains of Streptococcus suis is enhanced by the presence of suilysin. FEMS Immunol. Med. Microbiol. 26:25-35[CrossRef][Medline]. |
| 9. | Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-497. |
| 10. | Segers, R. P., T. Kenter, L. A. de Haan, and A. A. Jacobs. 1998. Characterisation of the gene encoding suilysin from Streptococcus suis and expression in field strains. FEMS Microbiol. Lett. 167:255-261[CrossRef][Medline]. |
| 11. |
Segura, M.,
J. Stankova, and M. Gottschalk.
1999.
Heat-killed Streptococcus suis capsular type 2 strains stimulate tumor necrosis factor alpha and interleukin-6 production by murine macrophages.
Infect. Immun.
67:4646-4654 |
| 12. | Tomasz, A., and K. Saukkonen. 1989. The nature of cell wall-derived inflammatory components of pneumococci. Pediatr. Infect. Dis. J. 8:902-903[Medline]. |
| 13. | Tuomanen, E., A. Tomasz, B. Hengstler, and O. Zak. 1985. The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J. Infect. Dis. 151:535-540[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»